Literature DB >> 12960344

HLA class II-restricted CD4+ T cell responses directed against influenza viral antigens postinfluenza vaccination.

Nancy A Danke1, William W Kwok.   

Abstract

The memory T cell response is polyclonal, with the magnitude and specificity of the response controlled in part by the burst size of T cells expanded from effector/memory precursors. Sensitive assays using HLA class II multimers were used to detect low-frequency Ag-specific T cells directed against influenza viral Ags in subjects immunized with the influenza vaccine. Direct ex vivo tetramer staining of PBMC from five individuals identified frequencies of hemagglutinin (HA) 306-318 tetramer binding CD4(+) T cells in the peripheral blood ranging from 1 in 600 to 1 in 30,000 CD4(+) T cells. These frequencies were validated by counting CFSE(low), tetramer-positive T cells after in vitro expansion. Low frequency of T cells directed to other influenza epitopes, including DRA1*0101/DRB1*0401-restricted matrix protein 60-73, DRA1*0101/DRB1*0101-restricted matrix protein 18-29, DRA1*0101/DRB1*0701-restricted HA 232-244 and DRA1*0101/DRB1*0101-restricted nucleoprotein 206-217 were also determined. T cells which occurred at a frequency as low as 1 in 350,000 could be ascertained by in vitro expansion of precursors. Peripheral HA(306-318)-responsive T cells expanded 2- to 5-fold following influenza vaccination. Examination of phenotypic markers of the HA(306-318)-responsive T cells in the peripheral blood indicated that the majority were CD45RA(-), CD27(+), CD25(-), CD28(+), and CD62L(-), while T cell clones derived from this population were CD45RA(-), CD27(-), CD25(+), CD28(+), and CD62L(-).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12960344     DOI: 10.4049/jimmunol.171.6.3163

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  40 in total

1.  Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health.

Authors:  Sefina Arif; Timothy I Tree; Thomas P Astill; Jennifer M Tremble; Amanda J Bishop; Colin M Dayan; Bart O Roep; Mark Peakman
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

2.  Ex vivo phenotype and frequency of influenza virus-specific CD4 memory T cells.

Authors:  Michaela Lucas; Cheryl L Day; Jessica R Wyer; Sharon L Cunliffe; Andrew Loughry; Andrew J McMichael; Paul Klenerman
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

3.  Transient immunological control during acute hepatitis C virus infection: ex vivo analysis of helper T-cell responses.

Authors:  A Ulsenheimer; M Lucas; N P Seth; J Tilman Gerlach; N H Gruener; A Loughry; G R Pape; K W Wucherpfennig; H M Diepolder; P Klenerman
Journal:  J Viral Hepat       Date:  2006-10       Impact factor: 3.728

Review 4.  Targeting T lymphocytes for immune monitoring and intervention in autoimmune diabetes.

Authors:  Roberto Mallone; Gerald T Nepom
Journal:  Am J Ther       Date:  2005 Nov-Dec       Impact factor: 2.688

5.  Expression of HLA-DP0401 molecules for identification of DP0401 restricted antigen specific T cells.

Authors:  Junbao Yang; Laurel Huston; Deanna Berger; Nancy A Danke; Andrew W Liu; Mary L Disis; William W Kwok
Journal:  J Clin Immunol       Date:  2005-09       Impact factor: 8.317

6.  Antigen-specific immune responses to influenza vaccine in utero.

Authors:  Deepa Rastogi; Chaodong Wang; Xia Mao; Cynthia Lendor; Paul B Rothman; Rachel L Miller
Journal:  J Clin Invest       Date:  2007-06       Impact factor: 14.808

7.  Ex vivo monitoring of antigen-specific CD4+ T cells after recall immunization with tetanus toxoid.

Authors:  Catherine Barbey; Estelle Pradervand; Nathalie Barbier; François Spertini
Journal:  Clin Vaccine Immunol       Date:  2007-07-18

Review 8.  Class II major histocompatibility complex tetramer staining: progress, problems, and prospects.

Authors:  Sabrina S Vollers; Lawrence J Stern
Journal:  Immunology       Date:  2008-03       Impact factor: 7.397

Review 9.  Immunogenetics of seasonal influenza vaccine response.

Authors:  Gregory A Poland; Inna G Ovsyannikova; Robert M Jacobson
Journal:  Vaccine       Date:  2008-09-12       Impact factor: 3.641

10.  Healthy human subjects have CD4+ T cells directed against H5N1 influenza virus.

Authors:  Michelle Roti; Junbao Yang; DeAnna Berger; Laurie Huston; Eddie A James; William W Kwok
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.